IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2024 Holdings

Filed 2024-05-15 | 12 holdings | $40.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$28.9M134,06872.0%
Biontech SE(BNTX)COM09075V102$11.1M120,00027.6%
Exelixis Inc(EXEL)COM30161Q104$37.2K1,566,1400.1%
United Therapeutics Corp(UTHR)COM91307C102$36.0K156,7140.1%
Taro Pharmaceutical IndusCOMM8737E108$27.4K647,8680.1%
Cardinal Health Inc(CAH)COM14149Y108$26.4K235,6560.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$19.6K1,124,5860.0%
Jazz Pharmaceuticals PLC(JAZZ)COMG50871105$12.2K101,1510.0%
Regeneron Pharmaceuticals(REGN)COM75886F107$12.0K12,4940.0%
Sanofi(SNY)COM80105N105$7.3K150,9590.0%
Alkermes PLC(ALKS)COMG01767105$7.0K257,5540.0%
Mural Oncology PLCCOMG63365103$43088,0010.0%